Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Holding CRSP?
Track your performance easily

Crispr Therapeutics AG (CRSP) Technical Analysis

8,413 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 0.58, suggesting Crispr Therapeutics AG is a Sell.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 48.14, while Crispr Therapeutics AG’s (CRSP) share price is $50.32, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 48.33, while Crispr Therapeutics AG’s (CRSP) share price is $50.32, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Nov 05, 2024, 03:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.22
45.57
48.16
49.51
52.10
53.45
56.04
Fibonacci
45.57
47.07
48.00
49.51
51.01
51.94
53.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Nov 05, 2024, 03:54 PM
Period
Simple
Exponential
MA5
48.92Buy
49.33Buy
MA10
48.37Buy
48.72Buy
MA20
47.85Buy
48.14Buy
MA50
47.21Buy
48.33Buy
MA100
50.78Sell
50.64Sell
MA200
58.13Sell
56.33Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 48.72, while Crispr Therapeutics AG’s (CRSP) share price is $50.32, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 50.64, while Crispr Therapeutics AG’s (CRSP) share price is $50.32, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $50.32 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 47.21, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $50.32 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 50.78, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $50.32 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 58.13, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Nov 05, 2024, 03:54 PM
Name
Value
Implied Action
RSI (14)
58.76
Neutral
STOCH (9,6)
65.61
Neutral
STOCHRSI (14)
65.61
Neutral
MACD (12,26)
0.58
Sell
ADX (14)
16.12
Buy
Williams %R
-20.28
Buy
CCI (14)
151.92
Sell
ATR (14)
1.93
-
Ultimate Oscillator
53.52
Neutral
ROC
5.29
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 58.76, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 16.12, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 151.92, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 5.29, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 58.76, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 0.58, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 48.92, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 47.85, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 47.21, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 58.13, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -20.28, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 151.92, which suggests CRSP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis